Glenmark has announced the upcoming launch of eribulin mesylate injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials. Glenmark’s eribulin mesylate injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results